1 - 25 of 63 results for author:"Orr-Urtreger A." in Literature citations
Results Customize
› Repeat search in UniProtKB (7)
| Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism. LRRK2 Ashkenazi Jewish Consortium Brain 135:3687-3698(2012) · Mapped (4) |
| Tnfalpha, Cox2 and AdipoQ adipokine gene expression levels are modulated in murine adipose tissues by both nicotine and nACh receptors containing the beta2 subunit. Gochberg-Sarver A., Kedmi M., Gana-Weisz M., Bar-Shira A., Orr-Urtreger A. Mol. Genet. Metab. 107:561-570(2012) · Mapped (5) |
| HIF1A C1772T polymorphism leads to HIF-1alpha mRNA overexpression in prostate cancer patients. Vainrib M., Golan M., Amir S., Dang D.T., Dang L.H., Bar-Shira A., Orr-Urtreger A., Matzkin H., Mabjeesh N.J. Cancer Biol. Ther. 13:720-726(2012) · Mapped (9) |
| Sperm epidermal growth factor receptor (EGFR) mediates alpha7 acetylcholine receptor (AChR) activation to promote fertilization. Jaldety Y., Glick Y., Orr-Urtreger A., Ickowicz D., Gerber D., Breitbart H. J. Biol. Chem. 287:22328-22340(2012) · Mapped (48) |
| Subunit composition of alpha5-containing nicotinic receptors in the rodent habenula. Scholze P., Koth G., Orr-Urtreger A., Huck S. J. Neurochem. 121:551-560(2012) · Mapped (19) |
| Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk. Gan-Or Z., Bar-Shira A., Dahary D., Mirelman A., Kedmi M., Gurevich T., Giladi N., Orr-Urtreger A. Arch. Neurol. 69:105-110(2012) · Mapped (4) |
| Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's disease. Gan-Or Z., Bar-Shira A., Gurevich T., Giladi N., Orr-Urtreger A. Neurogenetics 12:325-332(2011) · Mapped (4) |
| alpha4beta2 nicotinic acetylcholine receptors in the early postnatal mouse superior cervical ganglion. Scholze P., Ciuraszkiewicz A., Groessl F., Orr-Urtreger A., McIntosh J.M., Huck S. Dev Neurobiol 71:390-399(2011) · Mapped (9) |
| Gait alterations in healthy carriers of the LRRK2 G2019S mutation. Mirelman A., Gurevich T., Giladi N., Bar-Shira A., Orr-Urtreger A., Hausdorff J.M. Ann. Neurol. 69:193-197(2011) · Mapped (4) |
| Large-scale population screening for spinal muscular atrophy: clinical implications. Ben-Shachar S., Orr-Urtreger A., Bardugo E., Shomrat R., Yaron Y. Genet. Med. 13:110-114(2011) · Mapped (10) |
| Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes. David R., Ciuraszkiewicz A., Simeone X., Orr-Urtreger A., Papke R.L., McIntosh J.M., Huck S., Scholze P. Eur. J. Neurosci. 31:978-993(2010) · Mapped (17) |
| Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans. Lesage S., Patin E., Condroyer C., Leutenegger A.L., Lohmann E., Giladi N., Bar-Shira A., Belarbi S., Hecham N., Pollak P. et al. Hum. Mol. Genet. 19:1998-2004(2010) · Mapped (4) |
| Candidate-gene approach in fibromyalgia syndrome: association analysis of the genes encoding substance P receptor, dopamine transporter and alpha1-antitrypsin. Ablin J.N., Bar-Shira A., Yaron M., Orr-Urtreger A. Clin. Exp. Rheumatol. 27:S33-8(2009) · Mapped (11) |
| Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. Nizri E., Irony-Tur-Sinai M., Lory O., Orr-Urtreger A., Lavi E., Brenner T. J. Immunol. 183:6681-6688(2009) · Mapped (5) |
| Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. Sidransky E., Nalls M.A., Aasly J.O., Aharon-Peretz J., Annesi G., Barbosa E.R., Bar-Shira A., Berg D., Bras J., Brice A. et al. N. Engl. J. Med. 361:1651-1661(2009) · UniProtKB (1) |
| The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews. Thaler A., Ash E., Gan-Or Z., Orr-Urtreger A., Giladi N. J Neural Transm 116:1473-1482(2009) · Mapped (4) |
| LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease. Gan-Or Z., Bar-Shira A., Mirelman A., Gurevich T., Kedmi M., Giladi N., Orr-Urtreger A. Neurogenetics 11:121-125(2010) · Mapped (4) |
| Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries. Bar-Shira A., Hutter C.M., Giladi N., Zabetian C.P., Orr-Urtreger A. Neurogenetics 10:355-358(2009) · Mapped (4) |
| Dynamic modification strategy of the Israeli carrier screening protocol: inclusion of the Oriental Jewish Group to the cystic fibrosis panel. Reish O., Borochowitz Z.U., Adir V., Shohat M., Karpati M., Shtorch A., Orr-Urtreger A., Yaron Y., Shalev S., Fares F. et al. Genet. Med. 11:101-103(2009) · Mapped (45) |
| Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Gan-Or Z., Giladi N., Rozovski U., Shifrin C., Rosner S., Gurevich T., Bar-Shira A., Orr-Urtreger A. Neurology 70:2277-2283(2008) · Mapped (4) |
| Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract. Petrakis S., Irinopoulou T., Panagiotidis C.H., Engelstein R., Lindstrom J., Orr-Urtreger A., Gabizon R., Grigoriadis N., Sklaviadis T. Eur. J. Neurosci. 27:612-620(2008) · Mapped (15) |
| The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Orr-Urtreger A., Shifrin C., Rozovski U., Rosner S., Bercovich D., Gurevich T., Yagev-More H., Bar-Shira A., Giladi N. Neurology 69:1595-1602(2007) · Mapped (4) |
| Functional analysis of the Aurora Kinase A Ile31 allelic variant in human prostate. Matarasso N., Bar-Shira A., Rozovski U., Rosner S., Orr-Urtreger A. Neoplasia 9:707-715(2007) · Mapped (9) |
| FGFR1 over-expression in primary rhabdomyosarcoma tumors is associated with hypomethylation of a 5' CpG island and abnormal expression of the AKT1, NOG, and BMP4 genes. Goldstein M., Meller I., Orr-Urtreger A. Genes Chromosomes Cancer 46:1028-1038(2007) · Mapped (9) |
| Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulation. Scholze P., Orr-Urtreger A., Changeux J.P., McIntosh J.M., Huck S. Br. J. Pharmacol. 151:414-422(2007) · Mapped (9) |